Company profile for Myrobalan Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Myrobalan Therapeutics is a biotechnology company headquartered in Medford, Massachusetts, with a focus on developing oral neurorestorative therapies aimed at reversing key pathologies underlying brain dysfunctions and central nervous system (CNS) conditions. Myrobalan applies deep knowledge of neurological processes such as demyelination and neuroinflammation, along with innovative drug discovery tools, to create highly selec...
Myrobalan Therapeutics is a biotechnology company headquartered in Medford, Massachusetts, with a focus on developing oral neurorestorative therapies aimed at reversing key pathologies underlying brain dysfunctions and central nervous system (CNS) conditions. Myrobalan applies deep knowledge of neurological processes such as demyelination and neuroinflammation, along with innovative drug discovery tools, to create highly selective and brain-penetrant therapeutic candidates uniquely positioned for treating CNS conditions with significant unmet medical needs.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Medford, MA 02155
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Clinical Outsourcing

Clinical Outsourcing

Not Confirmed

envelop Contact Supplier

Clinical Outsourcing

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20250312951560/en/Myrobalan-Therapeutics-Awarded-a-Grant-from-the-National-Multiple-Sclerosis-Society-to-Advance-Development-of-MRO-002-in-Multiple-Sclerosis

BUSINESSWIRE
13 Mar 2025

https://www.businesswire.com/news/home/20241031361663/en

BUSINESSWIRE
31 Oct 2024

https://www.businesswire.com/news/home/20241010333901/en

BUSINESSWIRE
16 Oct 2024

https://www.businesswire.com/news/home/20240918866628/en

BUSINESSWIRE
18 Sep 2024

https://www.businesswire.com/news/home/20240725463217/en

BUSINESSWIRE
29 Jul 2024

https://www.businesswire.com/news/home/20240206866405/en

BUSINESSWIRE
07 Feb 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty